AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


AJPH First Look, published online ahead of print Nov 29, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
AJPH.2004.043471v1
96/1/79    most recent
Right arrow Submit a response
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tolley, E. E.
Right arrow Articles by Severy, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tolley, E. E.
Right arrow Articles by Severy, L. J.
Related Collections
Right arrow Social Science
Right arrow HIV/AIDS
Right arrow Prevention
Right arrow Other Statistics/Evaluation/Research
January 2006, Vol 96, No. 1 | American Journal of Public Health 79-83
© 2006 American Public Health Association
DOI: 10.2105/AJPH.2004.043471


ATTAINING HEALTH IN AN INEQUITABLE WORLD

Integrating Behavioral and Social Science Research Into Microbicide Clinical Trials: Challenges and Opportunities

Elizabeth E. Tolley, PhD and Lawrence J. Severy, PhD

Both authors are with Family Health International, Durham, NC.

Correspondence: Requests for reprints should be sent to Elizabeth E. Tolley, Family Health International, 2224 East NC 54, Durham, NC 27713 (email: btolley{at}fhi.org).

It has been argued that rigid thinking about the types and progression of research needed to evaluate health promotion interventions has stymied the process by which research is translated to action. This argument is particularly salient in the field of HIV/AIDS prevention.

We examined microbicide research and identified challenges that obstruct the integration of clinical trial and behavioral and social science research, thereby reinforcing linear programs of research. We found that behavioral and social science research can both support microbicide clinical trial performance and anticipate the information most needed for a rapid and successful introduction of future microbicide products.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Public Health Association